<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.loc.gov/METS/ https://www.loc.gov/standards/mets/mets.xsd" OBJID="oai:wwu.de:b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" LABEL="University of Muenster, Institutional Repository MIAMI"  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
          <mets:metsHdr CREATEDATE="2022-11-09T14:51:20">
            <mets:agent TYPE="OTHER" ROLE="OTHER" OTHERTYPE="SOFTWARE">
              <mets:name>Memory Alpha</mets:name>
            </mets:agent>
          </mets:metsHdr>
          <mets:dmdSec ID="DMD_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e">
            <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
              <mets:xmlData>
                <mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd" version="3.7">
                  <mods:titleInfo type="uniform" lang="eng">
                    <mods:title script="Latn">Conformational changes in ezrin analyzed by Förster resonance energy transfer</mods:title>
                  </mods:titleInfo>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/1080502386">
                    <mods:namePart type="given">Victoria</mods:namePart>
                    <mods:namePart type="family">Shabardina</mods:namePart>
                    <mods:namePart type="date">1988-</mods:namePart>
                    <mods:displayForm>Shabardina, Victoria</mods:displayForm>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">aut</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="personal" valueURI="http://d-nb.info/gnd/111048907">
                    <mods:namePart type="given">Volker</mods:namePart>
                    <mods:namePart type="family">Gerke</mods:namePart>
                    <mods:displayForm>Gerke, Volker</mods:displayForm>
                    <mods:affiliation>FB 13: Biologie</mods:affiliation>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">ths</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Universitäts- und Landesbibliothek Münster</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Münster, Westfalen / ULB</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Münster, Westfalen / Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:name type="corporate" valueURI="http://d-nb.info/gnd/5091030-9" altRepGroup="2">
                    <mods:namePart>Westfalen / Universität Münster / Universitäts- und Landesbibliothek</mods:namePart>
                    <mods:role>
                      <mods:roleTerm type="code" authority="marcrelator">own</mods:roleTerm>
                    </mods:role>
                  </mods:name>
                  <mods:genre>doctoralThesis</mods:genre>
                  <mods:genre authority="dct">Text</mods:genre>
                  <mods:originInfo>
                    <mods:dateIssued keyDate="yes">2015</mods:dateIssued>
                    <mods:dateOther>2015-12-08</mods:dateOther>
                    <mods:issuance>monographic</mods:issuance>
                  </mods:originInfo>
                  <mods:originInfo>
                    <mods:dateIssued encoding="w3cdtf">2015-12-21</mods:dateIssued>
                    <mods:dateModified encoding="w3cdtf">2015-12-21</mods:dateModified>
                    <mods:edition>[Electronic ed.]</mods:edition>
                  </mods:originInfo>
                  <mods:language>
                    <mods:languageTerm type="code" authority="iso639-2b">eng</mods:languageTerm>
                  </mods:language>
                  <mods:physicalDescription>
                    <mods:form>electronic</mods:form>
                    <mods:reformattingQuality>access</mods:reformattingQuality>
                    <mods:internetMediaType>application/pdf</mods:internetMediaType>
                    <mods:digitalOrigin>born digital</mods:digitalOrigin>
                  </mods:physicalDescription>
                  <mods:abstract lang="ger">Ezrin gehört zu der ERM Proteingruppe und seine Hauptfunktion besteht in der Verbindung zwischen dem Zytoskelett und der Zellmembran. Diese Arbeit demonstriert Veränderungen der Ezrin-Konformation während seiner Aktivierung und erklärt Synergismus der Aktivirungsfaktoren: Interaktion zwischen Ezrin und PIP2, Ezrin Phosphorylierung. Förster resonance energy transfer Technik wurde in dieser Arbeit angewendet.</mods:abstract>
                  <mods:abstract lang="eng">Ezrin, a member of the ERM (Ezrin-Radixin-Moesin) protein family, serves as a linker between cell membrane and cytoskeleton in the cells of all protozoans. Thereby, it is involved in cell motility, cell division, cell-cell adhesion and the maintainance of cell polarity. In resting cells ezrin exists in a so-called dormant state, where most of its binding sites are masked by an autoinhibitory association between N- and C-terminals. Ezrin activation is thought to be triggered by interaction with PIP2 and the C-terminal phosphorylation. In this study we probed ezrin’s conformational state by FRET (Förster resonance energy transfer) and showed that disruption of the N-C-terminals association occurs only when of both activating factors are applied.</mods:abstract>
                  <mods:tableOfContents lang="eng">Contents&#13;
Summary ......................................................................................................................................... V&#13;
1 Introduction .................................................................................................................................... 1&#13;
1.1 The ERM protein family ................................................................................................................ 1&#13;
1.2 ERM proteins and their conservative features ............................................................................ 1&#13;
1.3 Ezrin is involved in cell cortex organization and signaling cascades ............................................. 4&#13;
1.4 Dormant and activated states of ezrin.......................................................................................... 7&#13;
1.4.1 Role of PIP2 in the cell ............................................................................................................. 8&#13;
1.4.2 Protein phosphorylation as one of the main regulators of cell functioning ............................. 10&#13;
1.4.3 Structure and conformations of ezrin ..................................................................................... 11&#13;
1.5 Ezrin activation hypothesis ......................................................................................................... 16&#13;
1.6 Aim of the study and general experimental approach .............................................................. 20&#13;
2 Materials ....................................................................................................................................... 25&#13;
2.1 Chemicals and reagents .............................................................................................................. 25&#13;
2.2 Markers ....................................................................................................................................... 26&#13;
2.3 Kits ............................................................................................................................................... 26&#13;
2.4 Antibodies ................................................................................................................................... 27&#13;
2.5 Enzymes ..................................................................................................................................... 27&#13;
2.6 Cell lines ...................................................................................................................................... 27&#13;
2.7 Bacterial strains ........................................................................................................................... 28&#13;
2.8 DNA-constructs ........................................................................................................................... 28&#13;
2.8.1 Eukaryotic and bacterial expression vectors ........................................................................... 28&#13;
2.8.2 Oligonucleotides .................................................................................................................... 29&#13;
2.9 Equipment ................................................................................................................................... 29&#13;
2.10 Devices ...................................................................................................................................... 29&#13;
3 Methods ........................................................................................................................................ 31&#13;
3.1 Cell biology methods ................................................................................................................... 31&#13;
3.1.1 Cultivation of adherent eukaryotic cells .................................................................................. 31&#13;
3.1.2 Cryo-stocks ............................................................................................................................ 31&#13;
3.1.3 EGF stimulation experiments ................................................................................................ 31&#13;
3.1.4 Confocal immunofluorescence imaging.................................................................................. 31&#13;
3.1.5 Transient transfection ............................................................................................................ 32&#13;
3.1.6 Stable transfection ................................................................................................................. 33&#13;
&#13;
3.2 Molecular biology methods ........................................................................................................ 33&#13;
3.2.1 Plasmids cloning .................................................................................................................... 33&#13;
3.2.2 Maxi-preps ............................................................................................................................. 36&#13;
3.3 Biochemical methods .................................................................................................................. 36&#13;
3.3.1 SDS-PAGE ........................................................................................................................... 36&#13;
3.3.2 Western Blot analysis ............................................................................................................. 37&#13;
3.3.3 DNA gel-electrophoresis ....................................................................................................... 38&#13;
3.3.4 Bacterial expression and purification of the proteins .............................................................. 39&#13;
3.3.5 Recombinant expression and purification of proteins from HEK293-T cells ......................... 40&#13;
3.3.6 Fluorescent labeling of proteins ............................................................................................. 41&#13;
3.3.7 Bradford assay ....................................................................................................................... 42&#13;
3.3.8 Liposomes preparation .......................................................................................................... 42&#13;
3.3.9 Liposomes pelleting assay ...................................................................................................... 42&#13;
3.3.10 Supported lipid bilayer preparation and protein binding ....................................................... 43&#13;
3.3.11 Reflectometric Interference Spectroscopy - RIfS .................................................................. 44&#13;
3.3.12 Intra- and inter-molecular FRET on supported lipid bilayers ............................................... 44&#13;
3.3.13 Enzymatic protein digest ...................................................................................................... 45&#13;
4 Results ................................................................................................................................................ 47&#13;
4.1 Expression and purification of the recombinant ezrin, ezrinT567D and their GFP-fused derivatives using the BL21 strain of E.coli and HEK293T cells .......................................................... 48&#13;
4.2 Liposome pelleting assay: the fluorescent derivatives of ezrin bind to PIP2 and DOGS-Ni-NTA containing liposomes like the wild type protein ............................................................................... 50&#13;
4.3 EzrGFP and DGFP are recruited to the cell membrane in EGF activated A431 cells similar to endogenous ezrin .............................................................................................................................. 51&#13;
4.4 DyLight405EzrGFP is not suitable for FRET analysis ................................................................... 55&#13;
4.5 Cy3EzrGFP shows FRET ............................................................................................................... 56&#13;
4.6 Reflectometric Interference Spectroscopy (RIfS) showes binding of the Cy3-labeled ezrin derivatives to PIP2- and DOGS-Ni-NTA-containing SSLB ................................................................... 59&#13;
4.7 Fluorescent spectra, FRET in solution ......................................................................................... 61&#13;
4.8 Analysis of FRET efficiency on solid supported bilayers ............................................................. 64&#13;
5 Discussion ...................................................................................................................................... 73&#13;
5.1 GFP-tag does not change properties of ezrin in the cells and in in vitro binding assays ............ 73&#13;
5.2 Properties of Cy3EzrGFP and DyLight405EzrGFP as FRET constructs ......................................... 75&#13;
5.3 PIP2 binding and threonine 567 phosphorylation contribute to conformational change in ezrin simultaneously .................................................................................................................................. 76&#13;
&#13;
References ............................................................................................................................................ 81&#13;
Supplemental materials ........................................................................................................................ 91&#13;
Abbreviations ...................................................................................................................................... 105&#13;
Acknowledgements ............................................................................................................................. 107&#13;
Curriculum vitae ................................................................................</mods:tableOfContents>
                  <mods:targetAudience>specialized</mods:targetAudience>
                  <mods:subject>
                    <mods:topic lang="ger">Ezrin-Aktivierung; FRET; Ezrin-Konformation</mods:topic>
                  </mods:subject>
                  <mods:subject>
                    <mods:topic lang="eng">ezrin activation; FRET; ezrin conformation</mods:topic>
                  </mods:subject>
                  <mods:classification authority="ddc">570</mods:classification>
                  <mods:identifier type="urn">urn:nbn:de:hbz:6-37249521495</mods:identifier>
                  <mods:location>
                    <mods:url access="object in context">https://miami.uni-muenster.de/Record/b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e</mods:url>
                  </mods:location>
                  <mods:accessCondition type="use and reproduction">
                    <mods:extension>
                      <ma:maWrap xmlns:ma="http://memoryalpha.ulb.uni-muenster.de">
                        <ma:licence>
                          <ma:displayLabel>InC 1.0</ma:displayLabel>
                          <ma:targetUrl>https://rightsstatements.org/vocab/InC/1.0/</ma:targetUrl>
                        </ma:licence>
                      </ma:maWrap>
                    </mods:extension>
                  </mods:accessCondition>
                  <mods:recordInfo>
                    <mods:recordIdentifier>oai:wwu.de:b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e</mods:recordIdentifier>
                  </mods:recordInfo>
                </mods:mods>
              </mets:xmlData>
            </mets:mdWrap>
          </mets:dmdSec>
          <mets:amdSec ID="AMD_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e">
            <mets:rightsMD ID="RIGHTSMD_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVRIGHTS">
                <mets:xmlData>
                  <dv:rights xmlns:dv="http://dfg-viewer.de/">
                    <dv:owner>Universitäts- und Landesbibliothek Münster</dv:owner>
                  </dv:rights>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:rightsMD>
            <mets:digiprovMD ID="DIGIPROVMD_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e">
              <mets:mdWrap MDTYPE="OTHER" MIMETYPE="text/xml" OTHERMDTYPE="DVLINKS">
                <mets:xmlData>
                  <dv:links xmlns:dv="http://dfg-viewer.de/">
                    <dv:reference>https://miami.uni-muenster.de/Record/b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e</dv:reference>
                    <dv:presentation/>
                  </dv:links>
                </mets:xmlData>
              </mets:mdWrap>
            </mets:digiprovMD>
          </mets:amdSec>
          <mets:fileSec>
            <mets:fileGrp USE="DEFAULT">
              <mets:file MIMETYPE="application/pdf" CHECKSUM="945ebd4b246c68464e6b9104b998025e1c8665eb3ac851f0d72e2d658f39391e" CREATED="2015-12-21T13:58:38" CHECKSUMTYPE="SHA-256" SIZE="12110908" ID="ID_FIL_diss_shabardina.pdf_DEFAULT">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e/diss_shabardina.pdf" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
            <mets:fileGrp USE="DOWNLOAD">
              <mets:file MIMETYPE="application/pdf" ID="DOWb3c28dd8-dc4b-4ff3-80a7-e84f81eb417e">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/transfer/miami/b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" LOCTYPE="URL"/>
              </mets:file>
            </mets:fileGrp>
          </mets:fileSec>
          <mets:structMap TYPE="PHYSICAL">
            <mets:div ID="ID_PHY_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" TYPE="physSequence">
              <mets:div ID="ID_PHY_diss_shabardina.pdf">
                <mets:fptr FILEID="ID_FIL_diss_shabardina.pdf_DEFAULT"/>
              </mets:div>
            </mets:div>
          </mets:structMap>
          <mets:structMap TYPE="LOGICAL">
            <mets:div ADMID="AMD_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" DMDID="DMD_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" ID="ID_LOG_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" TYPE="Monograph">
              <mets:div ID="ID_LOG_ID_PHY_diss_shabardina.pdf"/>
            </mets:div>
          </mets:structMap>
          <mets:structLink>
            <mets:smLink xlink:from="ID_LOG_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e" xlink:to="ID_PHY_b3c28dd8-dc4b-4ff3-80a7-e84f81eb417e"/>
            <mets:smLink xlink:from="ID_LOG_ID_PHY_diss_shabardina.pdf" xlink:to="ID_PHY_diss_shabardina.pdf"/>
          </mets:structLink>
        </mets:mets>